Overcoming the Barriers to Managing Acute Ischemic Stroke
Reducing Time of Stroke Onset to Needle Time

Credit Area For Credit: Register/Login     View Activity As Guest




Release Date: May 20, 2015          Expiration Date: May 20, 2016



By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.




SUPPLEMENTAL  Slides


Download (PDF)Click here for a PDF of supplemental slides that accompany this webcourse. Download (PDF)

Program overview


Only approximately 25% of those who experience an acute ischemic stroke are admitted into a hospital within the 3- to 4.5-hour window recommended by guidelines. In addition, it has been reported that 8%-11.5% of patients presenting to the emergency department (ED) with an acute ischemic stroke are eligible for rt-PA, but only about 2% of those patients receive treatment.

Given the ideal window to initiate treatment in patients, it is important to ensure that stroke patients present at the ED within 2 hours of an initiating event, and that ED personnel complete a patient evaluation and qualification and initiate treatment within 60 minutes of patient arrival.

In a recent survey, 81% of clinicians noted that it took more than 30 minutes from event time to 911 call, with a delay greater than 60 minutes estimated by 57% of responders. Once in the ED, access to an emergency physician and the initial work-up were generally provided quickly. However, 52% of responders noted that 15 to 45 minutes were often required for a neurology consult and 73% of responders mentioned similar delays in taking and interpreting a CT scan. These findings provide a valuable framework for identifying and bridging important clinical gaps, and this CME activity is designed to assist this process


Faculty




Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

Executive Director of Interventional Cardiovascular Programs

Brigham and Women’s Hospital Heart & Vascular Center

Professor of Medicine, Harvard Medical School

Boston, MA

 

Read Biography



Lee H. Schwamm, MD, FAHA

Executive Vice Chairman, Department of Neurology
C. Miller Fisher Chair and Chief of MGH Stroke Services
Professor of Neurology, Harvard Medical School
Boston, MA

 

Read Biography


Target Audience


The target audience for this initiative includes emergency department physicians and other professionals who treat patients with acute ischemic stroke.


Educational Objectives


At the conclusion of this activity, participants should be able to demonstrate the ability to:
  • Discuss quality improvement initiatives focused on improving acute ischemic stroke care by reducing event-to-ED-door and door-to-needle times for eligible patients being treated with fibrinolytic therapy
  • Analyze the strengths of the clinical data that relate to the efficacy and safety of fibrinolytic therapy, including survival, quality of life outcomes, and hemorrhagic complications

Accreditation


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe.
The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION


The Potomac Center for Medical Education designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits TM.  Physicians should claim only the credits commensurate with the extent of their participation in the activity.

For questions regarding CME credit, the post-test, evaluation, please email contact@potomacme.org.


DISCLOSURE INFORMATION

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty and steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC: Research: Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix, Medtronic, Pfizer, Roche, Sanofi Aventis, The Medicines Company

Lee H. Schwamm, MD, FAHA
: Research: Genentech, Lundbeck, Medtronic, Penumbra

Non-faculty Disclosures

Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Barry Watkins, PhD; Blair St. Amand; Jay Katz, CHCP; Ashley Marostica: Nothing to disclose


FDA Disclosure


The content of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.


System Requirements


In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can b
e downloaded here.

INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT


There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test and evaluation. To complete the evaluation online, choose the best answer to each question. The estimated time for completion of this activity is 1.0 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test.  Participant is allowed to take the post-test three times.


Jointly Provided By

 
Potomac Center for Medical Education and Rockpointe

Supported By


Supported by an educational grant from Genentech, A Member of the Roche Group

By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.